Initial cognitive changes in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Movement Disorders

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.27330PMID 29543342PMCID PMC5920539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive Impairment in Parkinson s Disease

  2018cited by this paper
• Rating scales for cognition in Huntington's disease: Critique and recommendations

  2018cited by this paper
• Cognition among individuals along a spectrum of increased risk for Parkinson’s disease

  2018cited by this paper
• Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

  2018cited by this paper
• Cognitive changes in prodromal Parkinson's disease: A review

  2017influential reference
• Trajectories of prediagnostic functioning in Parkinson’s disease

  2017cited by this paper
• Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study

  2017cited by this paper
• Natural course of mild cognitive impairment in Parkinson disease

  2017cited by this paper
• Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

  2017cited by this paper
• A parsimonious scoring and normative calculator for the Parkinson’s disease mild cognitive impairment battery

  2017cited by this paper
• Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

  2017cited by this paper
• The Technology Crisis in Neuropsychology.

  2017cited by this paper
• Cognition and the course of prodromal Parkinson's disease

  2017cited by this paper
• Factor structure of the Montreal Cognitive Assessment items in a sample with early Parkinson's disease.

  2017cited by this paper
• Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

  2017cited by this paper
• Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease

  2016cited by this paper
• Normative comparisons for large neuropsychological test batteries: User-friendly and sensitive solutions to minimize familywise false positives

  2016cited by this paper
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cited by this paper
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cited by this paper
• Demographically Corrected Normative Standards for the Spanish Language Version of the NIH Toolbox Cognition Battery

  2016cited by this paper
• Accuracy of Patient and Care Partner Identification of Cognitive Impairments in Parkinson's Disease–Mild Cognitive Impairment

  2016cited by this paper
• Cognitive function in the early phase of Parkinson's disease, a five‐year follow‐up

  2015cited by this paper
• Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

  2015cited by this paper
• Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.

  2015cited by this paper
• Longitudinal study of normal cognition in Parkinson disease

  2015influential reference
• Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo‐controlled study

  2015cited by this paper
• Characterizing mild cognitive impairment in incident Parkinson disease

  2014cited by this paper
• Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life

  2014cited by this paper
• The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease

  2014cited by this paper
• Evolution of mild cognitive impairment in Parkinson disease

  2013cited by this paper
• NIH Toolbox for Assessment of Neurological and Behavioral Function

  2013cited by this paper
• Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.

  2013cited by this paper
• Measuring mild cognitive impairment in patients with Parkinson's disease

  2013cited by this paper
• Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

  2012cited by this paper
• Traditional neuropsychological correlates and reliability of the automated neuropsychological assessment metrics-4 battery for Parkinson's disease.

  2012cited by this paper
• Selection of Deep Brain Stimulation Candidates in Private Neurology Practices: Referral May Be Simpler than a Computerized Triage System

  2012cited by this paper
• Lower cognitive performance in healthy G2019S LRRK2 mutation carriers

  2012cited by this paper
• Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease

  2012influential reference
• Validation of the MDS‐UPDRS Part I for nonmotor symptoms in Parkinson's disease

  2012cited by this paper
• Computerized Neuropsychological Assessment Devices: Joint Position Paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology

  2012cited by this paper
• Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

  2012influential reference
• Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease

  2012cited by this paper
• Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

  2012cited by this paper
• The MoCA: Well-suited screen for cognitive impairment in Parkinson disease

  2011cited by this paper
• Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder.

  2011cited by this paper
• The MoCA

  2010cited by this paper
• Utility of the NeuroTrax Computerized Battery for Cognitive Screening in Parkinson's Disease: Comparison with the MMSE and the MoCA

  2010cited by this paper
• A recommended scale for cognitive screening in clinical trials of Parkinson's disease

  2010cited by this paper
• Mild cognitive impairment in Parkinson disease

  2010cited by this paper
• Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment

  2009cited by this paper
• Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

  2009cited by this paper
• Cognitive impairment in incident, untreated Parkinson disease

  2009cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008cited by this paper
• Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

  2007cited by this paper
• Defining mild cognitive impairment in Parkinson's disease

  2007cited by this paper
• Multivariate normative comparisons.

  2007cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices.

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• Tracking neuropsychological recovery following concussion in sport

  2006cited by this paper
• Cognitive profile of patients with newly diagnosed Parkinson disease

  2005cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Neuropsychological Profile of Patients with Parkinson’s Disease without Dementia

  2003cited by this paper
• Base rates of "impaired" neuropsychological test performance among healthy older adults.

  1998cited by this paper
• Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.

  1994cited by this paper
• Clinical Interventions in Aging Dovepress Assessment of Cognitive Impairment in Patients with Parkinson's Disease: Prevalence and Risk Factors

  year unknowncited by this paper

• The Effects of Art Therapy on Executive Functions and Attention in Parkinson's Disease: Systematic Review and Meta-Analysis.

  2026cites this paper
• Functioning, emotion, and pain perception of individuals with Parkinson's disease after deep brain stimulation surgery.

  2025cites this paper
• The hidden mediator between polycyclic aromatic hydrocarbon exposure and cognitive function of elder adults: FT3/FT4 ratio

  2025cites this paper
• Transcranial Random Noise Stimulation over the Dorsolateral Prefrontal Cortex in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study

  2025influential citation
• The Role of Cognitive Reserve in Coping with Subjective Cognitive Complaints: An Exploratory Study of People with Parkinson’s Disease (PwPD)

  2025cites this paper
• Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations

  2025cites this paper
• Modeling the Heterogeneity and Trajectories of Cognitive Dysfunction in Parkinson's Disease Using Partially Ordered Set (POSET) Models

  2025cites this paper
• Population Pharmacokinetic and Exposure‐Response Analysis of the Cognitive Effects of TAK‐071 in Participants With Parkinson Disease and Cognitive Impairment

  2025cites this paper
• A multi-modal study on cerebrovascular dysfunction in cognitive decline of de novo Parkinson’s disease

  2025cites this paper
• Nucleus Basalis of Meynert Volume and Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation of the Subthalamic Nucleus

  2025cites this paper
• Exploring relevant factors of cognitive impairment in the elderly Chinese population using Lasso regression and Bayesian networks

  2024cites this paper
• The relationship between objective and subjective executive function in Parkinson’s disease

  2024cites this paper
• Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions

  2024cites this paper
• Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation

  2023cites this paper
• Research Progress of Early Non-motor Symptoms of Parkinson's Disease

  2023cites this paper
• Comparison of core and process scores on the California Verbal Learning Test-3 for Parkinson’s disease and essential tremor patients

  2023cites this paper
• How sleep quality affects activities of daily living in Parkinson’s disease: the mediating role of disease severity and the moderating role of cognition

  2023cites this paper
• The Increase of Theta Power and Decrease of Alpha/Theta Ratio as a Manifestation of Cognitive Impairment in Parkinson’s Disease

  2023cites this paper
• Pharmaceutical Considerations of Translabial Formulations for Treatment of Parkinson's Disease: A Concept of Drug Delivery for Unconscious Patients.

  2022cites this paper
• Analyses of correct responses and errors on measures of verbal fluency among Parkinson’s disease and essential tremor patients

  2022cites this paper
• Prevalence and Clinical Characteristics of Dementia and Cognitive Impairment in Multiple System Atrophy: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints

  2022influential citation
• Neuropsychology of Parkinson's disease.

  2022cites this paper
• The Effect of Deep Brain Stimulation of the Subthalamic Nucleus on Language Function in Parkinson's Disease: A Systematic Review.

  2021cites this paper
• Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction

  2021cites this paper
• Does the Montreal Cognitive Assessment (MoCA) identify cognitive impairment profiles in Parkinson’s disease? An exploratory study

  2021cites this paper
• An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson’s Disease

  2021influential citation
• Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson’s Disease?

  2021cites this paper
• Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy

  2021cites this paper
• The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations

  2021cites this paper
• Changes in Metabolic Activity and Gait Function by Dual-Task Cognitive Game-Based Treadmill System in Parkinson’s Disease: Protocol of a Randomized Controlled Trial

  2021cites this paper
• Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.

  2021cites this paper
• Cognitive reserve, individual alpha frequency in Parkinson’s disease

  2020cites this paper
• Non-pharmacological interventions for Parkinson's disease mild cognitive impairment: future directions for research

  2020cites this paper
• Prodromal PD: A new nosological entity.

  2020cites this paper
• Cognitive Impairment and Dementia in Parkinson Disease.

  2020cites this paper
• Treatment of Nonmotor Symptoms Associated with Parkinson Disease.

  2020cites this paper
• Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?

  2020cites this paper
• Cognitive tests that identify high risk of conversion to dementia in Parkinson’s disease

  2020cites this paper
• Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment

  2020cites this paper
• Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?

  2020cites this paper
• Cognitive and functional changes in prediagnostic phase of Parkinson disease: A population-based study.

  2020cites this paper
• Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

  2020cites this paper
• The different syndromes in Parkinson's disease: an overview

  2020cites this paper
• Clinically assessing cognitive function in Parkinson's disease

  2020cites this paper
• Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study

  2019cites this paper
• Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.

  2019cites this paper
• Early detection of cognitive impairment in Parkinson’s disease with the use of the Wisconsin Card Sorting Test: correlations with Montreal Cognitive Assessment and smell identification test

  2019cites this paper
• Clinical utility of the INECO Frontal Screening for detecting Mild Cognitive Impairment in Parkinson’s disease

  2019cites this paper
• Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study

  2019cites this paper
• Troubles cognitifs légers et maladie de Parkinson

  2018cites this paper
• Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration

  2018cites this paper
• Measuring executive dysfunction in Parkinson’s disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E)

  2018cites this paper
• Psychotropic drug use and cognitive rehabilitation practice for elderly patients

  2018cites this paper
• [Eye as an object of investigation of cognitive impairment in Parkinson's disease].

  2018cites this paper
• LOWE 123 IFP-CIT BINDING TO THE STRIA AL DOPAMINE TRANSPORTER , BUT NOT TO TH EXTRASTRIATAL SEROTONIN TRANSPORTER , IN PARKINSON ’ S DISEASE COMPARED WITH DEMENTIA WITH LEWY BODIES 3

  2018cites this paper
• Is there auditory impairment in Parkinson's disease?

  2018cites this paper
• Neuropsychologische, neuropsychiatrische und elektroencephalografische Aspekte der Apathie bei Patienten mit der Parkinsonerkrankung

  2018cites this paper
• Existe comprometimento do sistema auditivo na doença de Parkinson

  2018cites this paper